ID

12644

Description

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362985

Link

https://clinicaltrials.gov/show/NCT01362985

Keywords

  1. 12/7/15 12/7/15 -
Uploaded on

December 7, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Leukemia NCT01362985

Eligibility Acute Leukemia NCT01362985

Criteria
Description

Criteria

background disease other than lymphoma or multiple myeloma (mm)
Description

background disease other than lymphoma or multiple myeloma (mm)

Data type

boolean

Alias
UMLS CUI [1]
C0023418
UMLS CUI [2]
C0205394
UMLS CUI [3]
C0024299
UMLS CUI [4]
C0026764
are younger than 18 years of age.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)
Description

received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)

Data type

boolean

Alias
UMLS CUI [1]
C1504389
received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))
Description

received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))

Data type

boolean

Alias
UMLS CUI [1]
C1955474
contraindication for g-csf
Description

contraindication for g-csf

Data type

boolean

Alias
UMLS CUI [1]
C0079459
UMLS CUI [2]
C1301624
transplants using plerixafor-mobilised cells from allogeneic donor
Description

transplants using plerixafor-mobilised cells from allogeneic donor

Data type

boolean

Alias
UMLS CUI [1]
C0185085
UMLS CUI [2]
C1955474
UMLS CUI [3]
C0411265
received transplant using plerixafor-mobilised bone marrow cells
Description

received transplant using plerixafor-mobilised bone marrow cells

Data type

boolean

Alias
UMLS CUI [1]
C0005955
UMLS CUI [2]
C1955474
UMLS CUI [3]
C0411265
routes of plerixafor administration other than subcutaneous
Description

routes of plerixafor administration other than subcutaneous

Data type

boolean

Alias
UMLS CUI [1]
C1955474
UMLS CUI [2]
C0205394
UMLS CUI [3]
C1522438
patients whose cells do not mobilize poorly
Description

patients whose cells do not mobilize poorly

Data type

boolean

Alias
UMLS CUI [1]
C0524864
other
Description

other

Data type

boolean

Alias
UMLS CUI [1]
C0205394
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor according to the european union (eu) label.
Description

adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0024299
UMLS CUI [3]
C0026764
UMLS CUI [4]
C1955474

Similar models

Eligibility Acute Leukemia NCT01362985

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
background disease other than lymphoma or multiple myeloma (mm)
Item
background disease other than lymphoma or multiple myeloma (mm)
boolean
C0023418 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0026764 (UMLS CUI [4])
Age
Item
are younger than 18 years of age.
boolean
C0001779 (UMLS CUI [1])
received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)
Item
received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)
boolean
C1504389 (UMLS CUI [1])
received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))
Item
received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))
boolean
C1955474 (UMLS CUI [1])
contraindication for g-csf
Item
contraindication for g-csf
boolean
C0079459 (UMLS CUI [1])
C1301624 (UMLS CUI [2])
transplants using plerixafor-mobilised cells from allogeneic donor
Item
transplants using plerixafor-mobilised cells from allogeneic donor
boolean
C0185085 (UMLS CUI [1])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
received transplant using plerixafor-mobilised bone marrow cells
Item
received transplant using plerixafor-mobilised bone marrow cells
boolean
C0005955 (UMLS CUI [1])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
routes of plerixafor administration other than subcutaneous
Item
routes of plerixafor administration other than subcutaneous
boolean
C1955474 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C1522438 (UMLS CUI [3])
patients whose cells do not mobilize poorly
Item
patients whose cells do not mobilize poorly
boolean
C0524864 (UMLS CUI [1])
other
Item
other
boolean
C0205394 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor
Item
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor according to the european union (eu) label.
boolean
C0001675 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C1955474 (UMLS CUI [4])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial